Downregulation of LGR4 decreases ARPE-19 cell migration. by Qiang Hou (495704)

Poly (I:C) decreases HIV-1 replication in PBMCs. by Christiane Rollenhage (762318)

c-Abl inhibition decreases ABCB1 expression and activity. by Jonathan T. Sims (278652)

Acupuncture decreases the level of p-c-Jun after SCI. by Jee Y. Lee (455790)

CMV infection decreases TER of polarized HCoEpiC. by Ekaterina Maidji (3797899)

Hypoxia dramatically decreased cGMP in cultured porcine retina. by Lorena Olivares-González (3352898)

Absence of FumC leads to decreased susceptibility to bactericidal antibiotics. by Stephanie D. Himpsl (8501868)

Loperamide decreases mechanical responsiveness of unmyelinated, nociceptive C-fibers. by Matthias Ringkamp (253465)

“…Dashed line indicates threshold assigned to afferents unresponsive to 25 g vF hair. B) Loperamide dose-dependently decreases the responsiveness to suprathreshold mechanical stimuli in both animal groups (ANOVA lesion: F_(3,35) = 10.3, p<0.001; ANOVA sham: F_(3,16) = 4.5, p<0.05). …”

Reduced callose synthesis in <i>pat</i> is associated with the decreased <i>CalS5</i> expression. by Shuang-Xi Xiong (8844044)

Decrease in GABA in APP mice. by Ksenia V. Kastanenka (3692380)

Cardamonin induced apoptosis and decreased the MMP of ovarian cancer cells. by Peiguang Niu (17044532)

VPA decreases cell proliferation. by Muriel Rhinn (406515)

Rapamycin decreases phosphorylation of S6. by Adam L. Hartman (308128)

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)

Resveratrol decreased nitrite production. by André Quincozes-Santos (108426)

Doxorubicin decreased the adiponectin levels. by Luana Amorim Biondo (2576386)

Sirt5 KO induces increased lysine succinylation and decreased ATP synthase activity in mouse heart mitochondria. by Mengli Zhang (6331172)

Increasing TPP side chain length decreases melanoma cell viability and clonogenic survival. by Kyle C. Kloepping (9928265)

“…A375 melanoma cells were treated with 0.25 μM, 0.5 μM, or 1.0 μM 5-, 8-, 10-, 12-,14-, or 16-TPP for (C) 24 h and (D) 48 h and analyzed for clonogenic survival (* represents when 12-, 14-, and 16-TPP were significant relative to 5-TPP and 8-TPP; Ψ represents when 10-TPP was significant relative to 5-TPP and 8-TPP; p < 0.05; n = 3 from 2 separate experiments; N = 6). …”

The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

“…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”

Loss of C9orf72 decreases mTOR activation. by Janet Ugolino (3359054)

“…Knockdown of C9orf72 significantly decreased p-S6K1 levels compared with cells treated with control shRNA (n = 3, *<i>p</i><0.5). …”